Medifocus (CVE:MFS) Reaches New 12-Month Low at $0.01

Medifocus Inc. (CVE:MFS) hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.01 and last traded at C$0.01, with a volume of 2000 shares traded. The stock had previously closed at C$0.01.

The company has a market cap of $1.85 million and a P/E ratio of -0.56. The stock has a 50-day moving average of C$0.01 and a 200 day moving average of C$0.02.

About Medifocus (CVE:MFS)

Medifocus Inc, a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue.

Featured Article: Float

Receive News & Ratings for Medifocus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifocus and related companies with MarketBeat.com's FREE daily email newsletter.